Publication | Open Access

Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice

Autoimmune DiseaseAllergyT-regulatory CellDiabetesImmunologyAutoimmunityNod MiceDiabetes MellitusImmunotherapyMedicineStable RemissionT Cell